Schedule 13G ownership disclosure

DMK PHARMACEUTICALS CORP PAR $0.0001

Security class unavailable · CUSIP: 00547W307

Event date: 2023-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-065587
Form type
SC 13G
Filer
DMK PHARMACEUTICALS Corp
CIK
CIK 887247
Filed
Aug 10, 2023
Reporting period
Aug 01, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub